# A Multicenter Phase II Pilot Open Label

> **NCT01830504** · PHASE2 · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 47 (actual)

## Conditions studied

- Thyroid Cancers

## Interventions

- **DRUG:** BKM120

## Key facts

- **NCT ID:** NCT01830504
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2013-04
- **Final completion:** 2017-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830504, "A Multicenter Phase II Pilot Open Label". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01830504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*